Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV). Objective: To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC). Materials and Methods: We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. Results: No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p < 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p < 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p < 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p < 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p < 0.0001). Conclusions: HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic hereditary disease characterized by multiple, bilateral cystic dilatation of the renal tubules. By the age of 50-60 years [1, 2] , 50% of patients undergo a gradual subversion of the renal parenchyma with an enlargement in the total kidney volume and eventually reach end-stage renal disease. Cardiovascular complications are the major cause of morbidity and mortality, with a cardiacrelated death that is estimated to be 1.6-to 3.2-fold higher in these patients than in the general population [3, 4] . Hypertension, endothelial dysfunction, systemic inflammation, and accelerated atherosclerosis are alterations found at a very early stage of the disease and are responsible for increasing both cardiovascular risks and progression towards end-stage renal disease. Hypertension is very common and often diagnosed before the onset of renal failure in 50-75% of ADPKD patients. The pathogenesis of hypertension in ADPKD is not yet fully elucidated, but some mechanisms have been revealed, such as activation of the reninangiotensin-aldosterone system (RAAS), impaired nitric oxide-related vasorelaxation, increased sympathetic nerve activity, increased plasma endothelin-1 concentration, and insulin resistance [5] . Autonomic dysfunction (AD) represents a cardiovascular risk factor that increases morbidity and mortality among patients. Autonomic activity can be evaluated with heart rate variability (HRV) [6] . In physiological conditions, dependence of HRV on heart rate is determined by the autonomic nervous system. In the course of pathological conditions such as myocardial ischemia, a reduction in parasympathetic control leads to sympathetic hyperactivity with cardiac electrical instability and left ventricular dysfunction [7] .
Recently, Chou et al. [8] have demonstrated that HRV represents a predictor of rapid kidney injury in chronic kidney disease patients on dialysis. They found that AD depends on the stage of chronic kidney disease and that the lowest HRV is present in end-stage renal disease. In essential hypertension, an imbalance has been reported between the sympathetic and parasympathetic systems [9] . To date, only one study has been conducted to evaluate heart rate recovery (HRR) in ADPKD patients. In 28 ADPKD patients without hypertension, Orscelik et al. [10] showed impaired HRR suggesting a link between ADPKD and the autonomic nervous system. The aim of the present study was to evaluate HRV, using time and frequency domain, in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC).
Materials and Methods
We have enrolled 65 patients from April to December 2018: 21 ADPKD patients (10 males), 20 patients with hypertension and organ damage (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. ADPKD patients with established cardiovascular disease like myocardial infarction, stroke, presence of atheromatous plaques on imaging, peripheral artery disease, and atrial fibril- lation were excluded. Others exclusion criteria, also for the hypertensive group, were diabetes, valvular abnormalities, arrhythmias, thyroid dysfunction, severe infections, malignancies, chronic liver disease, and chronic respiratory obstruction.
At the time of enrollment, none of the ADPKD and hypertensive patients were treated with β-blockers, antiarrhythmic drugs, ACE inhibitors, or angiotensin receptor blockers. Subjects' written consent was obtained. The study was conducted according to the criteria set by the Declaration of Helsinki and received approval of the local ethics committee.
Heart Rate Variability
All subjects underwent 24-h ambulatory 3-channel ECG Holter recording (Lifecard CF; Spacelabs Healthcare, Snoqualmie, WA, USA). HRV is a noninvasive marker to evaluate autonomic nervous system activity in time and frequency domain, according to the recommendation of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology [11] . At 10-min intervals, all the patients were analyzed with ECG recording, and the time registration was divided into 2 periods: day (7 a.m. to 12 p.m.) and night (12 p.m. to 7 a.m.). Artificial and arrhythmic data were excluded. In the time domain, we have evaluated the standard deviation of normal-to-normal RR intervals (SDNN) (ms) and the square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) that represent markers of the global sympathetic and the parasympathetic system, respectively. In the frequency domain, fast Fourier transform was used to obtain power spectral estimates of HRV to assess low frequency (LF: 0.04-0.15 Hz, modulated mainly by the sympathetic system) and high frequency (HF: 0.15-0.40 Hz, modulated by the parasympathetic system) in normalized units. The LF/HF ratio represents the sympathovagal balance. Data analyses were performed with software (Accuplus 363; Del Mar Avionics, Irvine, CA, USA)
Statistical Analysis
Data management and analysis were performed using IBM ® SPSS ® statistics 25.0 for Windows ® (IBM Corporation, Armonk, NY, USA). The normality of variables was tested by the Shapiro-Wilk normality test. All continuous normally distributed variables were expressed as means ± SD. Nonnormally distributed variables were described as medians and confidence intervals. The difference between numerical data was analyzed using nonparametric tests (Kruskal-Wallis test). Bivariate correlations and the degree of association between the variables were obtained with the Spearman test. Differences between qualitative variables were assessed by the Fisher exact test. A value of p < 0.05 was considered statistically significant. The Student t test was used to determine differences between the groups. Table 1 shows the anthropometric and clinical features of patients enrolled. No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. Table 2 shows HRV parameters in ADPKD, hypertensive patients, and HC. LF night showed a trend to higher values in ADPKD and hypertensive patients compared to HC (p < 0.01) ( Fig. 1A) . LF/HF night demonstrated high values in ADPKD and hypertensive patients compared to HC (p < 0.0001) ( Fig. 1B) . Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p < 0.01). HF night was also decreased in ADPKD and hypertensive patients compared to HC (p < 0.0001) (Fig. 1C) . The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p < 0.05) (Fig. 1D) .
Results

Discussion
In the present study, ADPKD patients reported statistical differences in the global autonomic activity represented by SDNN versus HC. In fact, when compared to HC, ADPKD patients showed a lower SDNN, much like that reported in hypertensive patients with organ damage. Previous studies reported that patients with SDNN < 50 ms after myocardial infarction have an increased risk of mortality at follow-up when compared to patients with SDNN > 100 ms [12] . Worldwide, essential hypertension represents the major cause of cardiovascular disease and death [13] . Several studies demonstrated AD in essential hypertension. The pathogenesis of hypertension is multifactorial, but a high sympathetic tone is activated in the early stages of essential hypertension. Thus, an imbalance between the sympathetic and parasympathetic tones is present both in the early and advanced stages of the disease characterized by organ damage. It has been hypothesized that high arterial stiffness due to elevated blood pressure can reduce baroreflex sensitivity increasing the sympathetic tone [14] . The pathogenesis of hypertension related to ADPKD differs from essential hypertension. The RAAS is more activated in ADPKD patients with hypertension than in patients with essential hypertension. Hypertension related to ADPKD occurs early and is due to cyst enlargement that causes renal ischemia with renin release, complicated by endothelial dysfunction, reduced nitric oxide, and sympathetic tone activation [15] . Considering that in ADPKD continuous RAAS stimulation worsens hypertension and accelerated cyst growth, it is not surprising to find in our study high LF and LF/HF levels, confirming, together with SDNN reduction a sympathetic prevalence. Furthermore, an imbalance between the sympathetic and parasympathetic tones has been detected, characterized by an abnormal LF/HF ratio especially during the night, with higher sympathetic tone due to circadian rhythm loss, while the HF component does not show the expected physiological increase. Cerasola et al. [16] found higher catecholamine levels in 30 hypertensive ADPKD patients than in 50 essential hypertensive patients. The authors suggest that increased activity of the sympathetic system could play a role in the pathogenesis of hypertension associated with ADPKD.
However, assessment of muscle sympathetic nerve activity, measured directly from the peroneal nerve by microneurography, is considered the gold standard to evaluate autonomic activity [17] . In a previous study, Orscelik et al. [10] already evaluated autonomic activity between normotensive ADPKD patients and HC. The authors demonstrated that impaired HRR index was correlated with normotensive ADPKD patients. Although in this study ADPKD patients were normotensive, the authors suggested an association with AD and ADPKD in the early stage of the disease. Autonomic function can be studied through HRV, HRR index, and systolic blood pressure variability. HRR is a simple tool for assessing the reduction in heart rate after the cessation of exercise and is related to parasympathetic activity. HRV refers to a variation in the beat-to-beat interval and measures the time and frequency domain able to evaluate indirectly the global sympathetic and parasympathetic system with sympathovagal balance. Thus, as previously shown in the literature, HRV parameters seem to be more sensitive than HRR to reveal increased sympathetic tone [18] . In our study, patients with ADPKD present the same HRV parameters as those found in essential hypertension with organ damage, such as myocardial infarction or stroke, for example. The essential hypertension group showed a median intima-media thickness of 1 mm (0.9-1.9), and 3 of them showed carotid artery stenosis. In the characteristics of hypertension mediated by organ damage, the presence of carotid plaques automatically reclassifies patients from intermediate to high risk in developing cardiovascular disease [13] . It has been hypothesized that renal bilateral involvement with ischemia and RAAS stimulation in ADPKD has a pathogenesis compatible with bilateral atherosclerotic renal artery stenosis [19, 20] . Recently, AD with low SDNN has been demonstrated also in atherosclerotic renal artery stenosis compared to HC. The authors suggest that inflammation could play a role in the pathway between autonomic tone and atherosclerosis [21] . In our study, no statistical differences were found between HRV parameters and renal function. Therefore, we believe that in ADPKD, hypertension related to cyst enlargement and RAAS activation could only worsen the autonomic system primarily damaged by the underlying disease.
Limitation of the Study
The limitations of our study are the relatively small cohort of hypertensive and ADPKD patients, and the cross-sectional, single-center design. Large studies with a high number of patients are needed to confirm the reported data.
Conclusions
We showed a significant reduction in HRV in ADPKD patients with respect to the HC. The 24-h ECG Holter with evaluation of HRV is one of the noninvasive tools to evaluate autonomic activity in predicting cardiovascular events. We suggest to include HRV assessment in association with traditional risk factors at an early stage of the disease to better stratify cardiovascular risk in ADPKD patients.
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